Health
Results: 961-972 of 9513

Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer

Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia

Dubai Health and AGFA HealthCare Mark 20 Years of Collaboration Supporting Dubai's Healthcare System

POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): NEW NAME FOR PCOS TO IMPROVE DIAGNOSIS AND CARE OF CONDITION AFFECTING 3.1 MILLION IN THE UK







